A  ||| S:0 E:2 ||| DT
clinical  ||| S:2 E:11 ||| JJ
prediction  ||| S:11 E:22 ||| NN
model  ||| S:22 E:28 ||| NN
to  ||| S:28 E:31 ||| TO
assess  ||| S:31 E:38 ||| VB
surgical  ||| S:38 E:47 ||| JJ
outcome  ||| S:47 E:55 ||| NN
in  ||| S:55 E:58 ||| IN
patients  ||| S:58 E:67 ||| NNS
with  ||| S:67 E:72 ||| IN
cervical  ||| S:72 E:81 ||| JJ
spondylotic  ||| S:81 E:93 ||| JJ
myelopathy ||| S:93 E:103 ||| NN
:  ||| S:103 E:105 ||| :
internal  ||| S:105 E:114 ||| JJ
and  ||| S:114 E:118 ||| CC
external  ||| S:118 E:127 ||| JJ
validations  ||| S:127 E:139 ||| NNS
using  ||| S:139 E:145 ||| VBG
the  ||| S:145 E:149 ||| DT
prospective  ||| S:149 E:161 ||| JJ
multicenter  ||| S:161 E:173 ||| JJ
AOSpine  ||| S:173 E:181 ||| JJ
North  ||| S:181 E:187 ||| NNP
American  ||| S:187 E:196 ||| NNP
and  ||| S:196 E:200 ||| CC
international  ||| S:200 E:214 ||| JJ
datasets  ||| S:214 E:223 ||| NN
of  ||| S:223 E:226 ||| IN
743  ||| S:226 E:230 ||| CD
patients  ||| S:230 E:239 ||| NNS
Clinical  ||| S:239 E:248 ||| JJ
prediction  ||| S:248 E:259 ||| NN
rules  ||| S:259 E:265 ||| NNS
are  ||| S:265 E:269 ||| VBP
valuable  ||| S:269 E:278 ||| JJ
tools  ||| S:278 E:284 ||| NNS
in  ||| S:284 E:287 ||| IN
a  ||| S:287 E:289 ||| DT
surgical  ||| S:289 E:298 ||| JJ
setting  ||| S:298 E:306 ||| NN
but  ||| S:306 E:310 ||| CC
should  ||| S:310 E:317 ||| MD
not  ||| S:317 E:321 ||| RB
be  ||| S:321 E:324 ||| VB
used  ||| S:324 E:329 ||| VBN
to  ||| S:329 E:332 ||| TO
guide  ||| S:332 E:338 ||| VB
clinical  ||| S:338 E:347 ||| JJ
practice  ||| S:347 E:356 ||| NN
until  ||| S:356 E:362 ||| IN
validated  ||| S:362 E:372 ||| NN
in  ||| S:372 E:375 ||| IN
other  ||| S:375 E:381 ||| JJ
populations ||| S:381 E:392 ||| NNS
.  ||| S:392 E:394 ||| .
The  ||| S:394 E:398 ||| DT
objective  ||| S:398 E:408 ||| NN
of  ||| S:408 E:411 ||| IN
this  ||| S:411 E:416 ||| DT
study  ||| S:416 E:422 ||| NN
was  ||| S:422 E:426 ||| VBD
to  ||| S:426 E:429 ||| TO
validate  ||| S:429 E:438 ||| VB
a  ||| S:438 E:440 ||| DT
clinical  ||| S:440 E:449 ||| JJ
prediction  ||| S:449 E:460 ||| NN
rule  ||| S:460 E:465 ||| NN
developed  ||| S:465 E:475 ||| VBN
to  ||| S:475 E:478 ||| TO
determine  ||| S:478 E:488 ||| VB
surgical  ||| S:488 E:497 ||| JJ
outcome  ||| S:497 E:505 ||| NN
in  ||| S:505 E:508 ||| IN
patients  ||| S:508 E:517 ||| NNS
with  ||| S:517 E:522 ||| IN
cervical  ||| S:522 E:531 ||| FW
spondylotic  ||| S:531 E:543 ||| FW
myelopathy  ||| S:543 E:554 ||| FW
( ||| S:554 E:555 ||| -LRB-
CSM ||| S:555 E:558 ||| NNP
) ||| S:558 E:559 ||| -RRB-
.  ||| S:559 E:561 ||| .
The  ||| S:561 E:565 ||| DT
study  ||| S:565 E:571 ||| NN
will  ||| S:571 E:576 ||| MD
also  ||| S:576 E:581 ||| RB
identify  ||| S:581 E:590 ||| VB
key  ||| S:590 E:594 ||| JJ
clinical  ||| S:594 E:603 ||| JJ
predictors  ||| S:603 E:614 ||| NN
of  ||| S:614 E:617 ||| IN
outcome  ||| S:617 E:625 ||| NN
at  ||| S:625 E:628 ||| IN
a  ||| S:628 E:630 ||| DT
global  ||| S:630 E:637 ||| JJ
level ||| S:637 E:642 ||| NN
.  ||| S:642 E:644 ||| .
This  ||| S:644 E:649 ||| DT
is  ||| S:649 E:652 ||| VBZ
a  ||| S:652 E:654 ||| DT
prospective  ||| S:654 E:666 ||| JJ
multicenter  ||| S:666 E:678 ||| JJ
cohort  ||| S:678 E:685 ||| JJ
study ||| S:685 E:690 ||| NN
.  ||| S:690 E:692 ||| .
Two-hundred  ||| S:692 E:704 ||| NNP
seventy-eight  ||| S:704 E:718 ||| NNP
and  ||| S:718 E:722 ||| CC
479  ||| S:722 E:726 ||| CD
surgical  ||| S:726 E:735 ||| JJ
CSM  ||| S:735 E:739 ||| NN
patients  ||| S:739 E:748 ||| NNS
enrolled  ||| S:748 E:757 ||| VBD
in  ||| S:757 E:760 ||| IN
theÂ AOSpine  ||| S:760 E:772 ||| NNP
CSM-North  ||| S:772 E:782 ||| NNP
American  ||| S:782 E:791 ||| NNP
( ||| S:791 E:792 ||| -LRB-
CSM-NA ||| S:792 E:798 ||| NNP
)  ||| S:798 E:800 ||| -RRB-
and  ||| S:800 E:804 ||| CC
CSM-International  ||| S:804 E:822 ||| NNP
( ||| S:822 E:823 ||| -LRB-
CSM-I ||| S:823 E:828 ||| NNP
)  ||| S:828 E:830 ||| -RRB-
studies ||| S:830 E:837 ||| NNS
,  ||| S:837 E:839 ||| ,
respectively ||| S:839 E:851 ||| RB
.  ||| S:851 E:853 ||| .
The  ||| S:853 E:857 ||| DT
outcome  ||| S:857 E:865 ||| NN
measure  ||| S:865 E:873 ||| NN
was  ||| S:873 E:877 ||| VBD
a  ||| S:877 E:879 ||| DT
Modified  ||| S:879 E:888 ||| NNP
Japanese  ||| S:888 E:897 ||| NNPS
Orthopedic  ||| S:897 E:908 ||| NNP
Association  ||| S:908 E:920 ||| NNP
( ||| S:920 E:921 ||| -LRB-
mJOA ||| S:921 E:925 ||| NNP
)  ||| S:925 E:927 ||| -RRB-
Scale ||| S:927 E:932 ||| NNP
.  ||| S:932 E:934 ||| .
A  ||| S:934 E:936 ||| DT
clinical  ||| S:936 E:945 ||| JJ
prediction  ||| S:945 E:956 ||| NN
model  ||| S:956 E:962 ||| NN
was  ||| S:962 E:966 ||| VBD
built  ||| S:966 E:972 ||| VBN
using  ||| S:972 E:978 ||| VBG
data  ||| S:978 E:983 ||| NNS
from  ||| S:983 E:988 ||| IN
272  ||| S:988 E:992 ||| CD
patients  ||| S:992 E:1001 ||| NNS
enrolled  ||| S:1001 E:1010 ||| VBD
in  ||| S:1010 E:1013 ||| IN
the  ||| S:1013 E:1017 ||| DT
CSM-NA  ||| S:1017 E:1024 ||| JJ
study ||| S:1024 E:1029 ||| NN
.  ||| S:1029 E:1031 ||| .
Bootstrapping  ||| S:1031 E:1045 ||| NNP
was  ||| S:1045 E:1049 ||| VBD
used  ||| S:1049 E:1054 ||| VBN
for  ||| S:1054 E:1058 ||| IN
internal  ||| S:1058 E:1067 ||| JJ
validation ||| S:1067 E:1077 ||| NN
.  ||| S:1077 E:1079 ||| .
The  ||| S:1079 E:1083 ||| DT
original  ||| S:1083 E:1092 ||| JJ
model  ||| S:1092 E:1098 ||| NN
was  ||| S:1098 E:1102 ||| VBD
externally  ||| S:1102 E:1113 ||| JJ
validated  ||| S:1113 E:1123 ||| NNS
using  ||| S:1123 E:1129 ||| VBG
data  ||| S:1129 E:1134 ||| NNS
on  ||| S:1134 E:1137 ||| IN
471  ||| S:1137 E:1141 ||| CD
patients  ||| S:1141 E:1150 ||| NNS
participating  ||| S:1150 E:1164 ||| VBG
in  ||| S:1164 E:1167 ||| IN
the  ||| S:1167 E:1171 ||| DT
CSM-I  ||| S:1171 E:1177 ||| JJ
study ||| S:1177 E:1182 ||| NN
.  ||| S:1182 E:1184 ||| .
The  ||| S:1184 E:1188 ||| DT
predictive  ||| S:1188 E:1199 ||| JJ
performance  ||| S:1199 E:1211 ||| NN
of  ||| S:1211 E:1214 ||| IN
the  ||| S:1214 E:1218 ||| DT
model  ||| S:1218 E:1224 ||| NN
was  ||| S:1224 E:1228 ||| VBD
evaluated ||| S:1228 E:1237 ||| VBN
,  ||| S:1237 E:1239 ||| ,
including  ||| S:1239 E:1249 ||| VBG
its  ||| S:1249 E:1253 ||| PRP$
discrimination ||| S:1253 E:1267 ||| NN
,  ||| S:1267 E:1269 ||| ,
measured  ||| S:1269 E:1278 ||| VBN
by  ||| S:1278 E:1281 ||| IN
area  ||| S:1281 E:1286 ||| NN
under  ||| S:1286 E:1292 ||| IN
the  ||| S:1292 E:1296 ||| DT
receiver-operating  ||| S:1296 E:1315 ||| JJ
curve  ||| S:1315 E:1321 ||| NN
( ||| S:1321 E:1322 ||| -LRB-
AUC ||| S:1322 E:1325 ||| NNP
) ||| S:1325 E:1326 ||| -RRB-
,  ||| S:1326 E:1328 ||| ,
and  ||| S:1328 E:1332 ||| CC
calibration ||| S:1332 E:1343 ||| NN
,  ||| S:1343 E:1345 ||| ,
assessed  ||| S:1345 E:1354 ||| VBN
by  ||| S:1354 E:1357 ||| IN
calibration  ||| S:1357 E:1369 ||| JJ
slope ||| S:1369 E:1374 ||| NN
,  ||| S:1374 E:1376 ||| ,
observed ||| S:1376 E:1384 ||| VBD
: ||| S:1384 E:1385 ||| :
expected  ||| S:1385 E:1394 ||| VBN
ratios ||| S:1394 E:1400 ||| NNS
,  ||| S:1400 E:1402 ||| ,
and  ||| S:1402 E:1406 ||| CC
Hosmer-Lemeshow  ||| S:1406 E:1422 ||| JJ
goodness-of-fit  ||| S:1422 E:1438 ||| JJ
test ||| S:1438 E:1442 ||| NN
.  ||| S:1442 E:1444 ||| .
The  ||| S:1444 E:1448 ||| DT
modified  ||| S:1448 E:1457 ||| JJ
original  ||| S:1457 E:1466 ||| JJ
model  ||| S:1466 E:1472 ||| NN
consisted  ||| S:1472 E:1482 ||| VBD
of  ||| S:1482 E:1485 ||| IN
six  ||| S:1485 E:1489 ||| CD
covariates ||| S:1489 E:1499 ||| NNS
:  ||| S:1499 E:1501 ||| :
age  ||| S:1501 E:1505 ||| NN
( ||| S:1505 E:1506 ||| -LRB-
odds  ||| S:1506 E:1511 ||| JJ
ratio  ||| S:1511 E:1517 ||| NN
[ ||| S:1517 E:1518 ||| -LRB-
OR ||| S:1518 E:1520 ||| NNP
] ||| S:1520 E:1521 ||| -RRB-
,  ||| S:1521 E:1523 ||| ,
0.96 ||| S:1523 E:1527 ||| CD
) ||| S:1527 E:1528 ||| -RRB-
,  ||| S:1528 E:1530 ||| ,
duration  ||| S:1530 E:1539 ||| NN
of  ||| S:1539 E:1542 ||| IN
symptoms  ||| S:1542 E:1551 ||| NNS
( ||| S:1551 E:1552 ||| -LRB-
0.76 ||| S:1552 E:1556 ||| CD
) ||| S:1556 E:1557 ||| -RRB-
,  ||| S:1557 E:1559 ||| ,
baseline  ||| S:1559 E:1568 ||| JJ
severity  ||| S:1568 E:1577 ||| NN
score  ||| S:1577 E:1583 ||| NN
( ||| S:1583 E:1584 ||| -LRB-
1.21 ||| S:1584 E:1588 ||| CD
) ||| S:1588 E:1589 ||| -RRB-
,  ||| S:1589 E:1591 ||| ,
psychiatric  ||| S:1591 E:1603 ||| JJ
comorbidities  ||| S:1603 E:1617 ||| NNS
( ||| S:1617 E:1618 ||| -LRB-
0.44 ||| S:1618 E:1622 ||| CD
) ||| S:1622 E:1623 ||| -RRB-
,  ||| S:1623 E:1625 ||| ,
impairment  ||| S:1625 E:1636 ||| NN
of  ||| S:1636 E:1639 ||| IN
gait  ||| S:1639 E:1644 ||| NNS
( ||| S:1644 E:1645 ||| -LRB-
2.48 ||| S:1645 E:1649 ||| CD
) ||| S:1649 E:1650 ||| -RRB-
,  ||| S:1650 E:1652 ||| ,
and  ||| S:1652 E:1656 ||| CC
smoking  ||| S:1656 E:1664 ||| NN
status  ||| S:1664 E:1671 ||| NN
( ||| S:1671 E:1672 ||| -LRB-
0.50 ||| S:1672 E:1676 ||| CD
) ||| S:1676 E:1677 ||| -RRB-
.  ||| S:1677 E:1679 ||| .
The  ||| S:1679 E:1683 ||| DT
AUC  ||| S:1683 E:1687 ||| NNP
for  ||| S:1687 E:1691 ||| IN
the  ||| S:1691 E:1695 ||| DT
original  ||| S:1695 E:1704 ||| JJ
model  ||| S:1704 E:1710 ||| NN
was  ||| S:1710 E:1714 ||| VBD
0.77  ||| S:1714 E:1719 ||| CD
( ||| S:1719 E:1720 ||| -LRB-
95 ||| S:1720 E:1722 ||| CD
%  ||| S:1722 E:1724 ||| NN
confidence  ||| S:1724 E:1735 ||| NN
interval  ||| S:1735 E:1744 ||| NNS
[ ||| S:1744 E:1745 ||| -LRB-
CI ||| S:1745 E:1747 ||| NNP
] ||| S:1747 E:1748 ||| -RRB-
:  ||| S:1748 E:1750 ||| :
0.71 ||| S:1750 E:1754 ||| CD
,  ||| S:1754 E:1756 ||| ,
0.82 ||| S:1756 E:1760 ||| CD
)  ||| S:1760 E:1762 ||| -RRB-
and  ||| S:1762 E:1766 ||| CC
across  ||| S:1766 E:1773 ||| IN
the  ||| S:1773 E:1777 ||| DT
bootstrap  ||| S:1777 E:1787 ||| JJ
replicates  ||| S:1787 E:1798 ||| NN
was  ||| S:1798 E:1802 ||| VBD
0.77  ||| S:1802 E:1807 ||| CD
( ||| S:1807 E:1808 ||| -LRB-
95 ||| S:1808 E:1810 ||| CD
%  ||| S:1810 E:1812 ||| NN
CI ||| S:1812 E:1814 ||| NNP
:  ||| S:1814 E:1816 ||| :
0.76 ||| S:1816 E:1820 ||| CD
,  ||| S:1820 E:1822 ||| ,
0.77 ||| S:1822 E:1826 ||| CD
) ||| S:1826 E:1827 ||| -RRB-
,  ||| S:1827 E:1829 ||| ,
reflecting  ||| S:1829 E:1840 ||| VBG
good  ||| S:1840 E:1845 ||| JJ
discrimination  ||| S:1845 E:1860 ||| NN
and  ||| S:1860 E:1864 ||| CC
internal  ||| S:1864 E:1873 ||| JJ
validity ||| S:1873 E:1881 ||| NN
.  ||| S:1881 E:1883 ||| .
The  ||| S:1883 E:1887 ||| DT
model  ||| S:1887 E:1893 ||| NN
tested  ||| S:1893 E:1900 ||| VBN
on  ||| S:1900 E:1903 ||| IN
the  ||| S:1903 E:1907 ||| DT
CSM-I  ||| S:1907 E:1913 ||| JJ
dataset  ||| S:1913 E:1921 ||| NN
yielded  ||| S:1921 E:1929 ||| VBD
an  ||| S:1929 E:1932 ||| DT
AUC  ||| S:1932 E:1936 ||| NNP
of  ||| S:1936 E:1939 ||| IN
0.74  ||| S:1939 E:1944 ||| NNP
( ||| S:1944 E:1945 ||| -LRB-
95 ||| S:1945 E:1947 ||| CD
%  ||| S:1947 E:1949 ||| NN
CI ||| S:1949 E:1951 ||| NNP
:  ||| S:1951 E:1953 ||| :
0.69 ||| S:1953 E:1957 ||| CD
,  ||| S:1957 E:1959 ||| ,
0.79 ||| S:1959 E:1963 ||| CD
) ||| S:1963 E:1964 ||| -RRB-
,  ||| S:1964 E:1966 ||| ,
a  ||| S:1966 E:1968 ||| DT
calibration  ||| S:1968 E:1980 ||| JJ
slope  ||| S:1980 E:1986 ||| NN
of  ||| S:1986 E:1989 ||| IN
0.75 ||| S:1989 E:1993 ||| CD
,  ||| S:1993 E:1995 ||| ,
and  ||| S:1995 E:1999 ||| CC
an  ||| S:1999 E:2002 ||| DT
insignificant  ||| S:2002 E:2016 ||| JJ
Hosmer-Lemeshow  ||| S:2016 E:2032 ||| JJ
test ||| S:2032 E:2036 ||| NN
.  ||| S:2036 E:2038 ||| .
The  ||| S:2038 E:2042 ||| DT
ORs  ||| S:2042 E:2046 ||| JJ
generated  ||| S:2046 E:2056 ||| NN
for  ||| S:2056 E:2060 ||| IN
baseline  ||| S:2060 E:2069 ||| NN
mJOA  ||| S:2069 E:2074 ||| NNS
( ||| S:2074 E:2075 ||| -LRB-
OR ||| S:2075 E:2077 ||| NNP
,  ||| S:2077 E:2079 ||| ,
1.26 ||| S:2079 E:2083 ||| CD
) ||| S:2083 E:2084 ||| -RRB-
,  ||| S:2084 E:2086 ||| ,
impairment  ||| S:2086 E:2097 ||| NN
of  ||| S:2097 E:2100 ||| IN
gait  ||| S:2100 E:2105 ||| NNS
( ||| S:2105 E:2106 ||| -LRB-
2.67 ||| S:2106 E:2110 ||| NNP
) ||| S:2110 E:2111 ||| -RRB-
,  ||| S:2111 E:2113 ||| ,
age  ||| S:2113 E:2117 ||| NN
( ||| S:2117 E:2118 ||| -LRB-
0.97 ||| S:2118 E:2122 ||| NNP
) ||| S:2122 E:2123 ||| -RRB-
,  ||| S:2123 E:2125 ||| ,
and  ||| S:2125 E:2129 ||| CC
smoking  ||| S:2129 E:2137 ||| NN
( ||| S:2137 E:2138 ||| -LRB-
0.55 ||| S:2138 E:2142 ||| CD
)  ||| S:2142 E:2144 ||| -RRB-
were  ||| S:2144 E:2149 ||| VBD
very  ||| S:2149 E:2154 ||| RB
similar  ||| S:2154 E:2162 ||| JJ
to  ||| S:2162 E:2165 ||| TO
the  ||| S:2165 E:2169 ||| DT
original  ||| S:2169 E:2178 ||| JJ
values  ||| S:2178 E:2185 ||| NNS
of  ||| S:2185 E:2188 ||| IN
1.28 ||| S:2188 E:2192 ||| CD
,  ||| S:2192 E:2194 ||| ,
2.39 ||| S:2194 E:2198 ||| CD
,  ||| S:2198 E:2200 ||| ,
and  ||| S:2200 E:2204 ||| CC
0.97 ||| S:2204 E:2208 ||| NNP
,  ||| S:2208 E:2210 ||| ,
respectively ||| S:2210 E:2222 ||| RB
.  ||| S:2222 E:2224 ||| .
Duration  ||| S:2224 E:2233 ||| NN
of  ||| S:2233 E:2236 ||| IN
symptoms  ||| S:2236 E:2245 ||| NNS
( ||| S:2245 E:2246 ||| -LRB-
OR ||| S:2246 E:2248 ||| NNP
,  ||| S:2248 E:2250 ||| ,
0.94 ||| S:2250 E:2254 ||| CD
)  ||| S:2254 E:2256 ||| -RRB-
had  ||| S:2256 E:2260 ||| VBD
a  ||| S:2260 E:2262 ||| DT
significantly  ||| S:2262 E:2276 ||| RB
different  ||| S:2276 E:2286 ||| JJ
odds  ||| S:2286 E:2291 ||| NNS
ratio  ||| S:2291 E:2297 ||| NN
than  ||| S:2297 E:2302 ||| IN
in  ||| S:2302 E:2305 ||| IN
the  ||| S:2305 E:2309 ||| DT
original  ||| S:2309 E:2318 ||| JJ
model ||| S:2318 E:2323 ||| NN
,  ||| S:2323 E:2325 ||| ,
but  ||| S:2325 E:2329 ||| CC
the  ||| S:2329 E:2333 ||| DT
direction  ||| S:2333 E:2343 ||| NN
of  ||| S:2343 E:2346 ||| IN
its  ||| S:2346 E:2350 ||| PRP$
relationship  ||| S:2350 E:2363 ||| NN
with  ||| S:2363 E:2368 ||| IN
outcome  ||| S:2368 E:2376 ||| NN
was  ||| S:2376 E:2380 ||| VBD
the  ||| S:2380 E:2384 ||| DT
same ||| S:2384 E:2388 ||| JJ
.  ||| S:2388 E:2390 ||| .
Psychiatric  ||| S:2390 E:2402 ||| JJ
comorbidities  ||| S:2402 E:2416 ||| NN
was  ||| S:2416 E:2420 ||| VBD
not  ||| S:2420 E:2424 ||| RB
a  ||| S:2424 E:2426 ||| DT
significant  ||| S:2426 E:2438 ||| JJ
predictor  ||| S:2438 E:2448 ||| NN
at  ||| S:2448 E:2451 ||| IN
an  ||| S:2451 E:2454 ||| DT
international  ||| S:2454 E:2468 ||| JJ
level ||| S:2468 E:2473 ||| NN
,  ||| S:2473 E:2475 ||| ,
likely  ||| S:2475 E:2482 ||| RB
because  ||| S:2482 E:2490 ||| IN
of  ||| S:2490 E:2493 ||| IN
underreporting ||| S:2493 E:2507 ||| NNS
:  ||| S:2507 E:2509 ||| :
only  ||| S:2509 E:2514 ||| RB
six  ||| S:2514 E:2518 ||| CD
patients  ||| S:2518 E:2527 ||| NNS
outside  ||| S:2527 E:2535 ||| IN
of  ||| S:2535 E:2538 ||| IN
North  ||| S:2538 E:2544 ||| NNP
American  ||| S:2544 E:2553 ||| NNP
centers  ||| S:2553 E:2561 ||| NNS
were  ||| S:2561 E:2566 ||| VBD
diagnosed  ||| S:2566 E:2576 ||| VBN
with  ||| S:2576 E:2581 ||| IN
depression  ||| S:2581 E:2592 ||| NN
or  ||| S:2592 E:2595 ||| CC
bipolar ||| S:2595 E:2602 ||| NN
.  ||| S:2602 E:2604 ||| .
The  ||| S:2604 E:2608 ||| DT
parameter  ||| S:2608 E:2618 ||| NN
estimates  ||| S:2618 E:2628 ||| VBZ
generated  ||| S:2628 E:2638 ||| VBN
from  ||| S:2638 E:2643 ||| IN
the  ||| S:2643 E:2647 ||| DT
original  ||| S:2647 E:2656 ||| JJ
analysis  ||| S:2656 E:2665 ||| NN
were  ||| S:2665 E:2670 ||| VBD
internally  ||| S:2670 E:2681 ||| RB
valid ||| S:2681 E:2686 ||| JJ
.  ||| S:2686 E:2688 ||| .
The  ||| S:2688 E:2692 ||| DT
original  ||| S:2692 E:2701 ||| JJ
model  ||| S:2701 E:2707 ||| NN
was  ||| S:2707 E:2711 ||| VBD
also  ||| S:2711 E:2716 ||| RB
externally  ||| S:2716 E:2727 ||| JJ
valid ||| S:2727 E:2732 ||| JJ
.  ||| S:2732 E:2734 ||| .
The  ||| S:2734 E:2738 ||| DT
most  ||| S:2738 E:2743 ||| RBS
significant  ||| S:2743 E:2755 ||| JJ
global  ||| S:2755 E:2762 ||| JJ
predictors  ||| S:2762 E:2773 ||| NN
of  ||| S:2773 E:2776 ||| IN
surgical  ||| S:2776 E:2785 ||| JJ
outcome  ||| S:2785 E:2793 ||| NN
were  ||| S:2793 E:2798 ||| VBD
baseline  ||| S:2798 E:2807 ||| JJ
myelopathy  ||| S:2807 E:2818 ||| JJ
severity ||| S:2818 E:2826 ||| NN
,  ||| S:2826 E:2828 ||| ,
age ||| S:2828 E:2831 ||| NN
,  ||| S:2831 E:2833 ||| ,
smoking  ||| S:2833 E:2841 ||| NN
status  ||| S:2841 E:2848 ||| NN
and  ||| S:2848 E:2852 ||| CC
impaired  ||| S:2852 E:2861 ||| JJ
gait ||| S:2861 E:2865 ||| NN
.  ||| S:2865 E:2867 ||| .
